ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ABVC Company Profile and Key Details

NASDAQ : ABVC

ABVC BioPharma, Inc.

$0.67

-0.0004-0.06%

At Close 4:00 PM

63.71

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ABVC Stock Price Chart

Stock Price Today

ABVC BioPharma, Inc. (ABVC) stock declined over -0.06%, trading at $0.67 on NASDAQ, down from the previous close of $0.67. The stock opened at $0.66, fluctuating between $0.66 and $0.67 in the recent session.

Stock Snapshot

0.6654

Prev. Close

0.66

Open

8.63M

Market Cap

12.98M

Number of Shares

0.6591

Day Low

0.6699

Day High

-0.82

P/E Ratio

86.61%

Free Float in %

-0.81

EPS (TTM)

1.11

Book Value

-0.53

Cash Flow per Share

32.76K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 20, 2025	0.67	0.67	0.66	0.67	32.76K
Mar 19, 2025	0.65	0.68	0.65	0.66	27.67K
Mar 18, 2025	0.66	0.71	0.65	0.66	87.83K
Mar 17, 2025	0.61	0.66	0.61	0.65	124.04K
Mar 14, 2025	0.65	0.68	0.61	0.65	116.94K
Mar 13, 2025	0.70	0.74	0.65	0.69	263.22K
Mar 12, 2025	0.65	0.70	0.65	0.70	152.09K
Mar 11, 2025	0.63	0.66	0.63	0.66	178.34K
Mar 10, 2025	0.65	0.66	0.63	0.63	186.48K
Mar 07, 2025	0.64	0.66	0.62	0.64	199.7K
Mar 06, 2025	0.65	0.66	0.63	0.64	321.02K
Mar 05, 2025	0.63	0.67	0.63	0.64	119.43K
Mar 04, 2025	0.69	0.72	0.63	0.63	96.65K
Mar 03, 2025	0.69	0.72	0.69	0.69	102.79K
Feb 28, 2025	0.76	0.78	0.67	0.69	357.41K
Feb 27, 2025	0.82	0.82	0.77	0.80	165.56K
Feb 26, 2025	0.72	0.84	0.71	0.81	479.73K
Feb 25, 2025	0.71	0.74	0.68	0.71	227.76K
Feb 24, 2025	0.68	0.82	0.68	0.74	1.34M
Feb 21, 2025	0.60	0.71	0.59	0.70	1.09M

Contact Details

Fremont, CA 94538

United States

Website: https://www.abvcpharma.comContact: 510 668 0881

About Company

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.

Frequently Asked Questions

What is the current ABVC BioPharma, Inc. (ABVC) stock price?

ABVC BioPharma, Inc. (NASDAQ: ABVC) stock price is $0.67 in the last trading session. During the trading session, ABVC stock reached the peak price of $0.67 while $0.66 was the lowest point it dropped to. The percentage change in ABVC stock occurred in the recent session was -0.06% while the dollar amount for the price change in ABVC stock was -$0.00.

ABVC's industry and sector of operation?

The NASDAQ listed ABVC is part of Biotechnology industry that operates in the broader Healthcare sector. ABVC BioPharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ABVC?

Dr. Chi-Hsin King Ph.D.
Chief Scientific Officer
Mr. Eugene Jiang
Chairman & Chief Bus. Officer
Dr. Uttam Yashwant Patil
Chief Executive Officer
Mr. Leeds Chow
Chief Financial Officer & Principal Accounting Officer
Dr. Tsung-Shann Jiang Ph.D.
Chief Scientific Officer, Chief Strategy Officer & Director
Dr. Tsung-Shann Jiang EMBA, Ph.D.
Chief Scientific Officer & Director
Dr. Uttam Yashwant Patil Ph.D.
Chief Executive Officer
Dr. Howard Doong M.D., Ph.D.
Pres & Chief Executive Officer

How ABVC did perform over past 52-week?

ABVC's closing price is 66.25% higher than its 52-week low of $0.40 where as its distance from 52-week high of $1.73 is -61.56%.

How many employees does ABVC have?

Number of ABVC employees currently stands at 16.

Link for ABVC official website?

Official Website of ABVC is: https://www.abvcpharma.com

How do I contact ABVC?

ABVC could be contacted at phone 510 668 0881 and can also be accessed through its website. ABVC operates from 44370 Old Warm Springs Boulevard, Fremont, CA 94538, United States.

How many shares of ABVC are traded daily?

ABVC stock volume for the day was 32.76K shares. The average number of ABVC shares traded daily for last 3 months was 529.23K.

What is the market cap of ABVC currently?

The market value of ABVC currently stands at $8.63M with its latest stock price at $0.67 and 12.98M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	16
Beta	0.67
Sales or Revenue	$152.43K
5Y Sales Change%	4.866%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology